Insider trade

Alnylam Pharmaceuticals (ALNY)Officer sold ~$399K

Bryan Supran, Officer at Alnylam Pharmaceuticals, sold ~$399K of Alnylam Pharmaceuticals shares.

~$399K
Approx. value · 1,758 sh @ $226.88: 13K
Holds after · shares reported

Traded: Oct 2, 2026
Filed: Oct 7, 2026

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alnylam Pharmaceuticals

For Alnylam Pharmaceuticals, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 24 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALNY page.

How this filing works

Other disclosures at Alnylam Pharmaceuticals

Everything OQRO holds on this company is on its ALNY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data